je.st
news
Nightstar announces $35 million Series B financing round
2015-11-09 20:03:37| IT Services - Topix.net
NightstaRx Ltd , a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates , one of the world's leading venture capital firms.
Tags: series
million
round
financing
Category:Information Technology